Family trust plans sale of 262,388 ZETA shares planned on NYSE (ZETA)
Rhea-AI Filing Summary
A family trust has filed a notice of proposed sale under Rule 144 to sell 262,388 shares of Class A Common Stock through Merrill Lynch on the NYSE, with an approximate sale date of 01/21/2026. The aggregate market value of the planned sale is listed as 5518019.64, while 238,040,782 shares of this class were outstanding at the time indicated. The securities were acquired on 02/17/2020 via estate planning transfers from the settlor of the trust, whose accounts are the source of the shares. The trust also sold 50,105 shares of Class A Common Stock in the past three months on 12/26/2025, generating gross proceeds of 999093.7.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing mean for ZETA investors?
This Form 144 shows that a family trust intends to sell 262,388 shares of Class A Common Stock on the NYSE under Rule 144. It is a disclosure of a planned sale by an existing holder, not an issuance of new shares by ZETA.
How many ZETA shares is the trust planning to sell under this Form 144?
The trust plans to sell 262,388 shares of ZETA Class A Common Stock, with an aggregate market value listed as 5518019.64.
How many ZETA Class A shares were outstanding compared to this planned sale?
The filing states that 238,040,782 shares of Class A Common Stock were outstanding, compared with the 262,388 shares covered by this planned sale.
When were the ZETA shares being sold originally acquired by the trust?
The Class A Common Stock being sold was acquired on 02/17/2020 through estate planning transfers from the settlor of the trust, who originally acquired the securities on 01/01/2015.
Has the same trust recently sold other ZETA shares?
Yes. Over the past three months, the family trust sold 50,105 shares of Class A Common Stock on 12/26/2025, receiving gross proceeds of 999093.7.
On which exchange and through which broker are the ZETA shares planned to be sold?
The filing lists Merrill Lynch as the broker, with the Class A Common Stock planned to be sold on the NYSE from an address at 200 Park Ave, New York, NY 10166.